| 구조 |
화학 이름 |
CAS |
MF |
 |
PJ-34 |
344458-19-1 |
C17H17N3O2 |
 |
5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one |
1048371-03-4 |
C17H13NO3 |
 |
Fenspiride hydrochloride |
5053-08-7 |
C15H21ClN2O2 |
![6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide](/CAS2/GIF/801312-28-7.gif) |
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide |
801312-28-7 |
C27H26N4O5S |
 |
S- (+)-Rolipram |
85416-73-5 |
C16H21NO3 |
 |
LY310762 |
192927-92-7 |
C24H27O2N2FHCl |
 |
Ziprasidone |
122883-93-6 |
C21H21ClN4OS |
 |
4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE |
199864-87-4 |
C17H16FN3 |
 |
BRL 15572 HYDROCHLORIDE |
193611-72-2 |
C25H28Cl2N2O |
![2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride](/CAS/GIF/694433-59-5.gif) |
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride |
694433-59-5 |
C20H21N3O2 |
 |
Onalespib |
912999-49-6 |
C24H31N3O3 |
 |
KW-2478 |
819812-04-9 |
C30H42N2O9 |
 |
PF-04929113 |
908115-27-5 |
C25H30F3N5O4 |
 |
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide |
908112-43-6 |
C23H27F3N4O3 |
![6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine](/CAS/GIF/873436-91-0.gif) |
6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine |
873436-91-0 |
C18H21IN6O2S |
 |
1-AZAKENPAULLONE |
676596-65-9 |
C15H10BrN3O |
 |
AZD 1080 |
612487-72-6 |
C19H18N4O2 |
 |
SB 415286 |
264218-23-7 |
C16H10ClN3O5 |
![ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE](/CAS/GIF/869363-13-3.gif) |
ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE |
869363-13-3 |
C25H15ClF2N4O2 |
 |
CYC-116 |
693228-63-6 |
C18H20N6OS |
 |
CCT129202 |
942947-93-5 |
C23H25ClN8OS |
 |
PF-03814735 |
942487-16-3 |
C23H25F3N6O2 |
 |
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
1396772-26-1 |
C32H37N5O3 |
 |
UNC 1999 |
1431612-23-5 |
C33H43N7O2 |
 |
UNC 0631 |
1320288-19-4 |
C37H61N7O2 |
 |
Hesperadin |
422513-13-1 |
C29H32N4O3S |
 |
LY2090314 |
603288-22-8 |
C28H25FN6O3 |
![2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-](/CAS/GIF/404951-53-7.gif) |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
 |
ZOTAROLIMUS |
221877-54-9 |
C52H79N5O12 |
 |
JAK3 Inhibitor |
211555-04-3 |
C16H14BrN3O3 |
![N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea](/CAS2/GIF/1144068-46-1.gif) |
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea |
1144068-46-1 |
C27H33N7O4 |
![N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea](/CAS/GIF/1207360-89-1.gif) |
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
1207360-89-1 |
C24H32N6O3 |
 |
PFI-1 |
1403764-72-6 |
C16H17N3O4S |
![2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO-](/CAS/GIF/252935-94-7.gif) |
2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- |
252935-94-7 |
C20H17Cl2N9O2 |
 |
4SC-201 |
864814-88-0 |
C16H19N3O4S |
 |
GLPG0634 |
1206101-20-3 |
C23H18N6O2 |
 |
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
 |
GSK 525762A |
1260907-17-2 |
C22H22ClN5O2 |
 |
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
 |
Filgotinib |
1206161-97-8 |
C21H23N5O3S |
 |
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
 |
GSK 343 |
1346704-33-3 |
C31H39N7O2 |
 |
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
 |
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
 |
Aurora A Inhibitor I |
1158838-45-9 |
C31H31ClFN7O2 |
 |
MK-5108 (VX-689) |
1010085-13-8 |
C22H21ClFN3O3S |
 |
CCT 137690 |
1095382-05-0 |
C26H31BrN8O |
 |
AR-42 |
935881-37-1 |
C18H20N2O3 |
 |
AMG 900 |
945595-80-2 |
C28H21N7OS |
 |
WP1066 |
857064-38-1 |
C17H14BrN3O |
 |
파클리니브 |
937272-79-2 |
C28H32N4O3 |
 |
Tazemetostat (EPZ-6438) |
1403254-99-8 |
C34H44N4O4 |
![5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine](/CAS/GIF/1224844-38-5.gif) |
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
 |
EPZ004777 |
1338466-77-5 |
C28H41N7O4 |
 |
PHA767491수산화물 |
845714-00-3 |
C12H11N3O |
 |
CH5132799 |
1007207-67-1 |
C15H19N7O3S |
 |
Abemaciclib mesylate (LY2835219) |
1231930-82-7 |
C28H36F2N8O3S |
 |
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
 |
PD0332991이세티오네이트 |
827022-33-3 |
C26H35N7O6S |
 |
HDBTU |
164861-52-3 |
C12H16F6N5O2P |
 |
PIK-294 |
900185-02-6 |
C28H23N7O2 |
 |
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
 |
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
 |
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
 |
BMS-265246 |
582315-72-8 |
C18H17F2N3O2 |
 |
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
 |
Ribociclib |
1211441-98-3 |
C23H30N8O |
![3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon](/CAS/GIF/194413-58-6.gif) |
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
 |
2-(7-아자벤조트리아졸-1-일)-1,1,3,3-테트라메틸우로늄테트라플루오로보레이트 |
873798-09-5 |
C10H15BF4N6O |
 |
A66 |
1166227-08-2 |
C17H23N5O2S2 |
 |
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
 |
VS-5584 |
1246560-33-7 |
C17H22N8O |
 |
CP-724714 |
537705-08-1 |
C27H27N5O3 |
![9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one](/CAS/GIF/1223001-51-1.gif) |
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
1223001-51-1 |
C24H15F3N4O |
 |
Torin 1 |
1222998-36-8 |
C35H28F3N5O2 |
 |
NVP-BGT226 |
1245537-68-1 |
C28H25F3N6O2.C4H4O4 |
 |
BAY 80-6946 (Copanlisib) |
1032568-63-0 |
C23H28N8O4 |
 |
PURVALANOL A |
212844-53-6 |
C19H25ClN6O |
 |
REVERSINE |
656820-32-5 |
C21H27N7O |
 |
TG003 |
300801-52-9 |
C13H15NO2S |
 |
AS 604850 |
648449-76-7 |
C11H5F2NO4S |
 |
AMG 458 |
913376-83-7 |
C30H29N5O5 |
![5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione](/CAS/GIF/958852-01-2.gif) |
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
958852-01-2 |
C18H11N3O2S |
 |
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
 |
7-Azabenzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate |
156311-85-2 |
C11H21F6N7OP2 |
 |
Ethyl 1-hydroxy-1H-1,2,3-triazole-4-carboxylate |
137156-41-3 |
C5H7N3O3 |
 |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
![2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid](/CAS2/GIF/1173900-33-8.gif) |
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
1173900-33-8 |
C22H24N4O4 |
 |
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
 |
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
 |
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
 |
CZC24832 |
1159824-67-5 |
C15H17FN6O2S |
 |
XL765 |
1349796-36-6 |
C31H29N5O6S |
![4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide](/CAS2/GIF/844442-38-2.gif) |
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide |
844442-38-2 |
C16H17Cl2N5O2 |
 |
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
677297-51-7 |
C18H14N6O2 |
 |
HNTU |
208462-94-6 |
C14H20F6N3O3P |
 |
PHA-848125 |
802539-81-7 |
C25H32N8O |
 |
WYE-354 |
1062169-56-5 |
C24H29N7O5 |
 |
PIK-75 Hydrochloride |
372196-77-5 |
C16H15BrClN5O4S |
 |
Capmatinib |
1029712-80-8 |
C23H17FN6O |